A study assessing the impact of choice of anticoagulant agents and the risk for bleeding in patients percutaneous coronary intervention: Insights from the California NCDR cath PCI registry.
Phase of Trial: Phase IV
Latest Information Update: 09 Oct 2016
At a glance
- Drugs Bivalirudin (Primary) ; Heparin (Primary)
- Indications Acute coronary syndromes; Thrombosis
- Focus Adverse reactions
- 09 Oct 2016 New trial record